Company Search:
Advanced Search
Sponsored Links
MusclePharm Corp Company Snapshot
MusclePharm Corp operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares MusclePharm Corp with three other companies in this sector in the United States: Avadel Pharmaceuticals PLC (2015 sales of $173.21 million of which 100% was Therapeutic Products), Enanta Pharmaceuticals Inc ($160.88 million of which 100% was Pharmaceutical Preparations), and Spectrum Pharmaceuticals, Inc. ($162.56 million of which 100% was Pharmaceuticals).

Sales Analysis. MusclePharm Corp reported sales of $166.86 million for the year ending December of 2015. This represents a decrease of 5.9% versus 2014, when the company's sales were $177.39 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MusclePharm Corp
  Stock Performance Chart for MusclePharm Corp
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 2.05
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 13.9%  
4 Weeks -2.4%   52 Weeks -6.8%  
MusclePharm Corp Key Data:
  Ticker: MSLP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 166,858,000
(Year Ending Jan 2016).
Employees: 248
  Currency: U.S. Dollars Market Cap: 28,361,094
  Fiscal Yr Ends: December Shares Outstanding: 13,834,680
  Share Type: Common Closely Held Shares: 4,511,520
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.